Bristol-Myers Squibb Company News - June 2, 2026

Bristol Myers Squibb Cancer Drug Beats Chemotherapy, Hitting Phase 3 Goals

Bristol Myers Squibb and partner SystImmune announced positive results from two Phase 3 trials for the investigational cancer drug izalontamab brengitecan...